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Background:  2 
The COVID-19 pandemic has placed significant pressure on health and social care. 3 
Survivors of COVID-19 may be left with substantial functional deficits requiring ongoing care.  4 
We aimed to determine whether preadmission frailty was associated with increased care 5 
needs at discharge for patients admitted to hospital with COVID-19. 6 
 7 
Methods:  8 
Patients were included if aged over 18 years old and admitted to hospital with COVID-19 9 
between 27th February and 10th June 2020. The Clinical Frailty Scale (CFS) was used to 10 
assess pre-admission frailty status. Admission and discharge care levels were recorded. 11 
Data were analysed using a mixed-effects logistic regression adjusted for age, sex, smoking, 12 
comorbidities, and admission CRP as a marker of severity of disease.  13 
 14 
Results:  15 
Thirteen hospitals included patients, 1671 patients were screened, 840 were excluded 16 
including 521 patients who died before discharge (31.1%). Of the 831 patients who were 17 
discharged, median age was 71 years (IQR, 58-81 years) and 369 (44.4%) were women. 18 
The median length of hospital stay was 12 days (IQR 6-24). Using the CFS, 438 (47.0%) 19 
had frailty (≥CFS 5), 193 (23.2%) required an increase in the level of care provided. 20 
Multivariable analysis showed that frailty was associated with an increase in care needs 21 
compared to patients without frailty (CFS 1-3). The adjusted odds ratios (aOR) were CFS 4: 22 
1.99 (0.97-4.11), CFS 5: 3.77 (1.94-4.11), CFS 6: 4.04 (2.09-7.82), CFS 7: 2.16 (1.12-4.20), 23 
and CFS 8: 3.19 (1.06-9.56).  24 
 25 
Conclusions:  26 
Many patients admitted with COVID-19 had increased care needs at discharge. Pre-27 
admission frailty was strongly associated with the need for an increased level of care needs 28 
at discharge. Our results have implications for service planning and public health policy 29 
suggesting that frailty screening should be utilised for predictive modelling and early 30 
individualised discharge planning.   31 
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Background  1 
 2 
COVID-19 has resulted in large numbers of people being admitted to hospital worldwide.[1-3] 3 
The UK government guidance published on 25th August 2020 estimates that 95% of patients 4 
admitted with COVID-19 may be discharged home, but 50% would require voluntary and 5 
community support, 45% health and social care services, 4% would be discharged to 6 
rehabilitation, and 1% into long-term care facilities [4]. However, these figures do not take into 7 
account those that already have these services in place pre-admission. Patients may 8 
experience functional deterioration requiring  temporary or permanent support from 9 
community social care and rehabilitation services on discharge from hospital .[5-7] A 10 
proportion of this group may require a change in living situation, for example a long term 11 
care facility such as residential or nursing home.  12 
 13 
People at higher risk of requiring hospital admission due to COVID-19 are older with greater 14 
levels of multimorbidity and frailty. [8-9]. Frailty represents increased vulnerability to stressors 15 
due to decline physiological systems and loss of homeostasis.[10,11] In a wide range of 16 
conditions, even after adjusting for age and comorbidity, frailty has been reported as an 17 
independent predictor of mortality, prolonged hospital stay, and increased care needs 18 
following hospital discharge. [13,14}. Similar effects due to COVID-19 have been reported 19 
including mortality and increased length of hospital stay. [9].  20 
 21 
To date most studies in older people with COVID-19 have focussed on mortality with little 22 
attention to functional outcomes. However, in older adults mortality is not always the most 23 
important outcome. Previous studies assessing the impact of frailty on quality of life in other 24 
conditions have demonstrated that for older adults independent living is a more important 25 
outcome than death. Higher value is placed on continuing day-to-day societal roles, reducing 26 
risk of isolation, loneliness, and avoiding poor future health outcomes [15-17]Currently is no 27 
literature describing factors associated with a loss of independence, or associated increase 28 
in care needs, after hospital admission post-acute COVID-19.The aim of this study was to 29 
investigate the association between preadmission frailty and change in level of care needs 30 
on discharge from hospital in patients admitted with COVID-19.  31 





Study design 3 
Data were obtained as part of a multicentre observational study: COPE (COVID-19 in Older 4 
People study). The study was authorised by the Health Research Authority (20/HRA/1898) in 5 
the UK, and the Ethics Committee of Policlinico Hospital Modena (Reference 6 
369/2020/OSS/AOUMO) in Italy. Full study details can be found within the COPE protocol [18] 7 
and the main study findings are reported elsewhere.[9] This manuscript follows the STROBE 8 
statement for reporting of cohort studies. Investigators carried out standardisation training in 9 
both data collection and CFS assessment. A central MACRO database, hosted by King’s 10 
Clinical Trials Unit (KCTU), was used to enter data centrally. 11 
 12 
Setting 13 
The COPE-Discharge study used an established network of twelve UK sites and one Italian 14 
site. The UK centres included: Ysbyty Ystrad Fawr in Caerphilly, Royal Gwent Hospital in 15 
Newport, Nevill Hall Hospital in Abergavenny, University Hospital of Wales in Cardiff, 16 
Southmead Hospital in Bristol, Aberdeen Royal Infirmary, Royal Alexandra Hospital in 17 
Paisley, Inverclyde Royal Hospital, Salford Royal Hospital, Glasgow Royal Infirmary, 18 
Maidstone Hospital and Ysbyty Gwynedd in Bangor. The Italian centre was the University 19 
Hospital of Modena Policlinico.  20 
 21 
Participants 22 
Each site research team screened hospital admission lists daily. The ethical approval was 23 
such that formal written consent from participants was deemed as not being required as all 24 
data were routinely collected in hospital records. 25 
 26 
Inclusion/exclusion criteria 27 
The study included consecutive hospitalised patients aged 18 years or older with a 28 
confirmed diagnosis of COVID-19 admitted between 27th February and 10th June 2020; 29 
diagnostic criteria included laboratory confirmed SARS-CoV-2 positive swab or a clinical 30 
diagnosis of COVID-19 based on signs, symptoms and supporting radiology. Patients were 31 
excluded due to: missing care level at admission and discharge; were not discharged from 32 





The primary outcome was increased care needs at discharge. Care was recorded as an 1 
ordinal variable, with seven-levels of increasing dependence care needs: at home without 2 
formal carers, own home with carers (formal or informal), intermediate care; increased 3 
number of daily carer visits, sheltered care, residential home, and nursing home.  4 
The number of daily carer visits required by patients was measured at admission and 5 
discharge. Sheltered care was accommodation of private independent units with shared 6 
facilities such as gardens and lounges, and a warden on site. Residential care was defined 7 
as 24-hour supported care managed by non-nursing trained care staff. Nursing care 8 
comprised service users receiving 24-hour support from nursing staff, requiring assistance 9 
with most personal daily activities or support with complex physical and/or psychological 10 
needs. Intermediate care varied depending on local provision and was defined as short-term 11 
care (either in an institution or individual’s home) designed to facilitate the transition from 12 
hospital to home. [19,20]. Intermediate care services develop person centred goals aimed at 13 
optimising independence and wellbeing of individuals through collaborative multidisciplinary 14 
holistic assessment and interventions.  15 
 16 
 17 
Covariates  18 
Demographic and clinical characteristics recorded at admission were: age, sex, smoking 19 
status (never, previous, or current), C-reactive protein (CRP) as a marker of disease 20 
severity, estimated glomerular filtration rate (eGFR), previous history of coronary artery 21 
disease (CAD), diabetes mellitus, chronic obstructive pulmonary disease (COPD), and 22 
hypertension (no, yes not on treatment, and yes on treatment). 23 
 24 
Frailty was scored based on a functional status history from two-weeks prior to admission, 25 
and was measured using the Clinical Frailty Scale (CFS). The CFS is a 9-point score, from 1 26 
being very fit, 2 well, 3 managing well, 4 living with very mild frailty, 5 living with mild frailty, 6 27 
living with moderately frailty, 7 living with severe frailty, 8 living with very severe frailty, and 9 28 
terminally ill but otherwise living with severe frailty [14]. For the purpose of the analyses CFS 29 
categories 1-3 were grouped and used as a reference group. In each site the assessment of 30 
CFS in patients was undertaken by a clinical teams comprising of a combination of 31 
consultant geriatricians, emergency physicians, and intensive care consultants. For all 32 
COVID-19 patients admitted to hospital the CFS was documented in a dedicated section on 33 
the admission notes. To safeguard data quality each principal investigator ensured adequate 34 
knowledge within the data collection team of frailty scoring. 35 
 36 
Statistical Analysis 37 
7 
 
We analysed the change in care level using a mixed-effects logistic regression, fitted with a 1 
random effect model to account for variation occurring at each hospital site. Care level was 2 
associated with baseline frailty and adjusted for: patient age group (<65, 65-79, ≥80 years 3 
old), sex, smoking status (never smoked, ex-smoker, current smoker), CRP (≥40mg/L taken 4 
as abnormal); diabetes (no/yes); hypertension (no/yes/yes and on treatment); coronary 5 
artery disease (no/yes), and reduced renal function (eGFR <60, ≥60 ml/min/1.73m²). Both 6 
crude odds ratios (OR) and adjusted odds ratios (aOR) were calculated with 95% confidence 7 
intervals (95% CI). Analysis was carried out using Stata version 15. 8 
 9 
We carried out a sensitivity analysis to assess longer term increased dependence by 10 
excluding patients that were discharged with intermediate care.  11 





As per CONSORT flow diagram (Figure 1) a total of 1671 patient records were entered into 3 
the COPE-Discharge database from 13 sites. Eight hundred and forty patients (840) were 4 
excluded: 112 patients due to missing care level at admission and discharge, 202 patients 5 
due to being alive still in hospital, and 526 had died in hospital.  6 
 7 
Of the 831 patients meeting the inclusion criteria  (Table 1), the median patient age was 71 8 
years (58-81 [IQR], range 19 to 100) and 369 (44.4%) were women. The median length of 9 
hospital stay was 12 days (6-24 [IQR], 0-145 [min-max]), 388 (46.7%) patients were 10 
considered to be living with frailty (CFS 5 to 9). Of the  included patients, 30 (3.6%) were 11 
under 65 years old and had an increased level of care. Of the 30 patients, 9 went from living 12 
independently at admission to requiring a carer, and 13 required intermediate care. There 13 
were 36 patients with a missing care level at discharge were imputed as not experiencing an 14 
increased care. 15 
 16 
Before hospital admission, 596 patients (71.7%) lived independently at home without a carer 17 
and a further 74 (8.9%) lived at home with carer support. The remaining 19.1% were living in 18 
either a sheltered, residential, or nursing care setting (Table 2). Across the 13 sites, 193 19 
(23.2%) patients were discharged with an increase in care level compared with that 20 
documented on admission. Fewer patients under 65 years old (30 out of 315, 9.5%) required 21 
an increase in care level compared with those of aged 80 years or older (87/242, 35.9%).   22 
 23 
As shown in Table 2, of 596 patients who were living at home without formal care before 24 
admission, 144 (24.2%) required an increase level of care at discharge. Of 74 patients who 25 
were living at home with carers before admission, 16 (21.6%) required an increased level of 26 
care. Of 158 patients who came from a sheltered accommodation, residential or nursing 27 
home, 24 (15.1%) required increased level of care. An increased care level occurred in 28 
10.2%, 12.6% and 13.1%, for the least frail categories for CFS of 1, 2 and 3. This compared 29 
to CFS 4: 20.0%, CFS 5: 36.9%, CFS 6: 38.5%, CFS 7: 26.1%, and CFS 8: 36.4%. 30 
 31 
In the crude logistic regression analysis, CFS was associated with an increase in care at 32 
discharge. Compared to CFS 1-3: CFS 4 OR=2.71 (95% CI 1.38-5.34, p=0.004); CFS 5 33 
OR=5.63 (95% CI 3.08-10.27, p<0.0001); CFS 6 OR=5.90 (95% CI 3.24-10.75, <0.0001); 34 
CFS 7 OR=3.50 (95% CI 1.90-6.47, p<0.0001); CFS 8 OR=4.30 (95%CI 1.53-12.09, 35 
p=0.006). The covariates associated with increased level of care at discharge were: age 36 
9 
 
(compared to <65 years: 65-79 OR=3.71 (95% CI 2.18-6.30, p<0.0001); >80 OR=5.79 (95% 1 
CI 3.35-9.98, p<0.0001), and elevated CRP (≥40mg/L) OR=0.65( 95% CI 0.45-0.94, 2 
p=0.022). 3 
 4 
Of the 831 included participants, 810 (97.5%) exhibited complete data and were included in 5 
the mixed-effects multivariable logistic regression analysis. After adjustment for the other 6 
comorbidities and CRP on admission, an increase in level of care at discharge was 7 
associated with frailty. Compared to CFS 1-3: CFS 4 aOR=1.99 (95% CI 0.97-4.11, 8 
p=0.062); CFS 5 aOR=3.77 (95% CI 1.94-7.32, p<0.0001); CFS 6 aOR=4.04 (95% CI 2.09-9 
7.82, p<0.0001); CFS 7 aOR=2.16 (95%CI 1.12-4.20, p=0.022); and CFS 8 aOR=3.19 (95% 10 
CI 1.06-9.56, p=0.039).Other covariates associated with increased level of care were: age 11 
(compared to <65 years: 65-79 aOR=2.82 (95% CI 1.57-5.06, p=0.001); >80 aOR=3.87  12 
(95% CI 2.07-7.26, p<0.0001), and CAD (aOR=0.49 95%CI 0.29-0.82, p=0.007).  13 
 14 
A sensitivity analysis carried out that only included patients that received a longer term 15 
increase in care (by removing intermediate care) at discharge found frailty was associated 16 




Our study has demonstrated that pre-admission frailty status is associated with a person’s 2 
level of independence after discharge from hospital following admission with COVID-19. 3 
Although many patients had no formal care prior to admission, almost a quarter acquired 4 
COVID-19 related functional dependence exhibited by additional care required on discharge. 5 
These findings are in keeping with other studies demonstrating worse functional outcomes 6 
associated with greater pre-hospital levels of frailty [21].  7 
 8 
Although not synonymous with advancing age, frailty is more prevalent in the older 9 
population, and as a consequence older people are more likely to require care. These data 10 
work have shown that risk of increased care needs following hospitalisation with COVID-19 11 
is also associated with increasing age those over 80 years old significantly more likely to 12 
require increased care at discharge than younger people. 13 
 14 
This association of frailty and age with increased functional dependence on discharge can 15 
assist with early identification at the point of hospital admission of people at risk of needing 16 
more care. These data can aid clinicians in providing early tailored assessments and 17 
management plans to patients. One paradigm of this tailored assessment is comprehensive 18 
geriatric assessment (CGA) effected through geriatric medicine clinicians in conjunction with 19 
the multidisciplinary team. CGA produces a personalised and integrated management plan 20 
using a multimodal, multimorbidity, and multidisciplinary approach over time. It has been 21 
shown to reduce post-acute long term functional dependence and mortality [22-24]. Ensuring 22 
CGA trained clinicians are embedded into acute hospital pathways will allow early screening 23 
of vulnerable patients and the chance to modify post-COVID outcomes. 24 
 25 
These data may be unique to hospital admissions during the pandemic and not pertain to 26 
non-COVID times as hospital-based teams are being faced with unique challenges 27 
streamlined discharge processes aimed at maintaining capacity within the acute setting, 28 
reduced access to specialist inpatient therapy resources due to high service demand, 29 
sickness related staff absences, and the breakdown of pre-pandemic informal care 30 
arrangements due to social distancing restrictions. [4]. It is difficult to interpret if these data 31 
reflect the Department of Health’s estimate that 50% of patients would be able to be 32 
discharge home without care: 50.7% in this cohort returned to their own home with no 33 
support, but figure this excludes the 19% in this study admitted from sheltered 34 
accommodation or a care home, and whether the Department of Health estimate includes 35 
these groups. [4] Furthermore, these findings have implications for both health and social 36 
11 
 
care funding. A large economic package will be required to provide adequate support for a 1 
more dependent population post-acute COVID-19. Local providers can use these data to 2 
anticipate short term budgets based on the frailty statuses of the hospitalised population. 3 
Future research should focus on the trajectory of patient’s COVID-19 acquired functional 4 
dependence to aid in longer term financial planning. Future studies should examine 5 
population based frailty scoring and the same associations of increased level of care in order 6 
to improve the regional and national social care predicted spend [4].  7 
To minimise the personal and societal burden of COVID-19 related functional decline and 8 
increased care needs, urgent strategies are required: firstly to avoid transmission of the virus 9 
through public health techniques such as contact tracing, infection control measures, and 10 
social distancing including shielding; secondly, modification of frailty pre-admission may 11 
ameliorate the risk of post-acute deterioration [25-29]; thirdly post-acute rehabilitation through 12 
specialist multidisciplinary rehabilitation services need to be targeted at those who have 13 
been affected to promote a return to pre-admission function  [30-32]. 14 
 15 
Strengths and limitations 16 
This is a multicentre study with a large sample size receiving real world care. Data were 17 
collected and curated by clinicians with an interest in older adults and processes aimed at 18 
maximising data completion and decreasing bias. Baseline patient characteristics and 19 
clinical outcomes demonstrated are in line with other COVID-19 publications suggesting 20 
external validity for example, almost three quarters of patients in this cohort were 65 years of 21 
age or older consistent with published evidence [1-3]. 22 
The study had several limitations: data to be cautious include the inter-hospital consistency 23 
of the services delivered within the term intermediate care, not collected due to limited time; 24 
the difference between crude and adjusted effect of CAD, the use of the CFS in people of all 25 
ages as this tool has been primarily validated in populations aged over 65 years. This study 26 
describes increased care level at the time of hospital discharge but not beyond that time.  27 
  28 
Conclusions 29 
Frailty is associated with increased level of care post-acute COVID-19. In this study 23.2% 30 
of discharged patients required an increased care level. This study suggests that future 31 
public health approaches must take into account the large number of patients with increased 32 
care needs, and position adequate resources to ensure robust supported discharge 33 
schemes for those admitted to hospital. Frailty screening should become standard practice 34 
at admission in order to identify patients early who are most likely to benefit multidisciplinary 35 
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